| Name | Title | Contact Details |
|---|
We are working to methodically engineer durable gene therapies for people with devastating diseases.
There are approximately 7,000 rare disorders worldwide. Each day more are being discovered. 95% of rare diseases have not one single FDA approved treatment. Glycomine develops therapeutics for diseases which have no treatment options.
ArQule, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Arixa Pharmaceuticals™ is developing oral antibiotics for resistant Gram-negative infections, an urgent need. Our lead program is an oral prodrug of Avibactam®, a broad spectrum beta-lactamase inhibitor recently approved by FDA. We have addressed and solved the medicinal chemistry issues which complicate the prodrugging of this class of compounds, and expect to receive broad composition of matter patent protection.
Future Family is where women, men and couples start their fertility journey. The company`s mission is to make fertility care accessible and affordable to all.